CRP and metabolic syndrome: Finally, patients in the active arm also showed an improvement in NHDL-C levels, classically elevated in MetS, which seems to be notable because of its contribution to cardiovascular risk and endothelium damages, also confirmed by the decrement in CRP-Hs values found during AP treatment.